January 4, 2025 - 20:21

The Union Health Ministry has announced its vigilance in response to the rising cases of Human Metapneumovirus (HMPV) reported in China. As the situation unfolds, officials are closely monitoring developments and have reached out to the World Health Organization (WHO) for timely updates on the outbreak.
Health authorities emphasize that India is well-prepared to manage any potential increase in respiratory illnesses. The ministry has assured citizens that robust surveillance systems and healthcare protocols are in place to address any cases that may arise.
In light of the outbreak, the ministry is also reinforcing the importance of public health measures, including vaccination and hygiene practices, to mitigate risks. The focus remains on ensuring that healthcare facilities are equipped to handle any surge in respiratory infections.
As the global health community watches the situation in China, India's proactive stance aims to safeguard public health and maintain readiness against respiratory pathogens.
October 2, 2026 - 03:30
Rethinking Healing: The Impact of Dance on Brain HealthOne doctor is encouraging a fresh perspective on healing by merging contemporary medical practices with ancient traditions. This approach highlights the potential benefits of dance not just for...
October 1, 2026 - 04:09
Lakers Kick Off Training Camp With Positive Health Report From Coach RedickThe Los Angeles Lakers have officially started their training camp, with all the faces finally getting a chance to work together on the basketball floor ahead of the upcoming season. New head coach...
September 29, 2026 - 20:01
Maternal Health Discussion Follows High-Profile TrialAccording to the Ohio Department of Children and Youth, depression is a common problem during and after pregnancy. The agency notes that mood changes are not unusual for new and expecting mothers,...
September 29, 2026 - 03:12
Opioid settlement funds could bridge some health gapsWhen Maura Healey served as Massachusetts attorney general, she took legal action in July 2021 against companies that made, distributed, and sold prescription opioids. The state argued that their...